OptimizeRx Q4 Earnings Call Highlights [Yahoo! Finance]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Yahoo! Finance
of $24.3 million , with Q4 revenue of $32.2 million , a Q4 gross margin of and operating cash flow of $18.7 million , while cash rose to $23.4 million Updated 2026 outlook and contracting headwinds: Management now expects 2026 revenue of $109–114 million and adjusted EBITDA of $21–25 million , citing softness from a market shift away from managed services (about $9 million in H1 2025) and MFN-related shorter contracts that leave contracted revenue excluding managed services roughly 15–20% behind pace. Capital allocation and strategic positioning: The board authorized a $10 million share repurchase while prioritizing debt paydown (current debt $26.3 million ), and management highlighted stronger-than-expected growth among mid-tier/long-tail manufacturers and described AI as a potential commercial tailwind rather than a disruption. Interested in OptimizeRx Corp.? Here are five stocks we like better. OptimizeRx (NASDAQ:OPRX) reported fourth-quarter and full-year fiscal 2025 resul
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- OptimizeRx (OPRX) had its price target lowered by Lake Street Capital from $24.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
- OptimizeRx (OPRX) had its price target lowered by Roth Mkm from $32.00 to $18.00. They now have a "buy" rating on the stock.MarketBeat
- OptimizeRx (OPRX) had its "buy" rating reaffirmed by B. Riley Financial, Inc.. They now have a $11.00 price target on the stock, down from $28.00.MarketBeat
- OptimizeRx (OPRX) had its price target lowered by Stephens from $17.00 to $10.00. They now have an "equal weight" rating on the stock.MarketBeat
OPRX
Earnings
- 3/5/26 - Beat
OPRX
Sec Filings
- 3/5/26 - Form 8-K
- 2/13/26 - Form 4
- 12/23/25 - Form 4/A
- OPRX's page on the SEC website